Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Possibilities of Diffusion-Weighted Magnetic Resonance Imaging in Determining the Burden of a Tumor in Patients with Follicular Lymphoma

Ekaterina S Nesterova, MD PhD, Galina A Yatsyk, MD PdD, Natalia S Lutsik, MD, Sergey K. Kravchenko, MD PhD, Eduard G Gemdzhian, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5264.

https://doi.org/10.1182/blood-2019-126502

Published: 2019

Journal Articles

Efficacy of Maintenance Therapy Following Auto-HSCT Depending on MRD Status in Patients with Multiple Myeloma

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Maiia V. Firsova, MD PhD, Irina V. Galtseva, PhD, Julia Davydova, Eduard G. Gemdzhian, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3432.

https://doi.org/10.1182/blood-2018-99-112790

Published: 2018

Journal Articles

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

Maiia V. Firsova, Larisa P. Mendeleeva, MD PhD Prof, Alla M. Kovrigina, MD PhD, Olga S. Pokrovskaya, MD PhD, Natalia L. Deineko, MD, Maxim V. Solovev, MD, Maria V. Nareyko, MD, Larisa A. Kuzmina, MD PhD, Eduard G. Gemdzhian, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5358.

https://doi.org/10.1182/blood.V130.Suppl_1.5358.5358

Published: 2017

Journal Articles

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Olga S. Pokrovskaya, MD PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Maiia V. Firsova, Maria V. Nareyko, MD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3294.

https://doi.org/10.1182/blood.V130.Suppl_1.3294.3294

Published: 2017

Journal Articles

Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)

Maxim V. Solovev, MD PhD, Larisa P. Mendeleeva, MD PhD Prof, Olga S. Pokrovskaya, MD PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Maya Firsova, MD, Irina Galtseva, MD PhD, Julia Davydova, MD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 2260.

https://doi.org/10.1182/blood.V128.22.2260.2260

Published: 2016

Journal Articles

Intensive Chemotherapy of 107 Primary Mediastinal B-Cell Lymphoma Patients. Single Center Experience

Jana Konstantinovna Mangasarova, MD PhD, Sergey Kirillovich Kravchenko, MD PhD, Aminat Umaraskhabovna Magomedova, MD PhD, Anna Misyurina, MD PhD, Elena Baryakh, MD PhD, Vladimir Ivanovich Vorobiev, MD PhD, Eduard G. Gemdzhian, PhD, Ekaterina Nesterova, MD PhD, Alisa Igorevna Gilenko, Liliya Gorenkova, MD PhD, Ekaterina Penskaya, Oleg Victorovich Margolin, MD PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 5494.

https://doi.org/10.1182/blood.V126.23.5494.5494

Published: 2015

Journal Articles

Hemostasis in Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy

Evdokia S. Urnova, MD PhD, Larisa P. Mendeleeva, MD PhD, Olga S. Pokrovskaya, MD PhD, Marina A. Gracheva, PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Ivan D. Tarandovsky, PhD, Maiia V. Firsova, MD, Mariya V. Nareiko, MD, Elena A. Seregina, PhD, Anna N. Balandina, PhD, Fazoil I. Ataullakhanov, PhD Prof., Sergei A. Vasil'ev, MD PhD Prof., Valeri G. Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 5388.

https://doi.org/10.1182/blood.V126.23.5388.5388

Published: 2015

Journal Articles

Clinical and Morphological Features of Different Variants Castleman's Disease

Anait L. Melikyan, MD PhD, Elena K. Egorova, MD PhD, Alla M. Kovrigina, MD PhD Prof., Irina N. Subortseva, MD PhD, Elena A. Gilyazitdinova, MD, Eduard G. Gemdzhian, PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 5591.

https://doi.org/10.1182/blood.V126.23.5591.5591

Published: 2015

Journal Articles

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Anna E. Lukina, MD PhD, Elena A. Baryakh, MD PhD, Alla M. Kovrigina, MD PhD Prof., Eduard G. Gemdzhian, PhD, Vsevolod A. Misyurin, PhD, Sergey K. Kravchenko, MD PhD, Vladimir I. Vorobyev, MD PhD, Jana K. Mangasarova, MD PhD, Aminat U. Magomedova, MD PhD, Yuri U. Polyakov, PhD, Tatiana N. Obukhova, PhD, Eugene E. Zvonkov, MD PhD, Anna K. Morozova, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5902.

https://doi.org/10.1182/blood.V124.21.5902.5902

Published: 2014

Journal Articles

Front-Line High Dose Therapy with Following Autologous Stem Cell Transplantation (ASCT) for Follicular Lymphoma Patients

Ekaterina S. Nesterova, MD PhD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD Prof., Eduard G. Gemdzhian, PhD, Aminat U. Magomedova, MD PhD, Elena A. Bariakh, MD PhD, Vladimir I. Vorobyev, MD PhD, Ekaterina A. Iliushkina, MD, Dmitry S. Mariin, MD, Natalia G. Chernova, MD PhD, Olga A. Gavrilina, MD, Anna E. Lukina, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5908.

https://doi.org/10.1182/blood.V124.21.5908.5908

Published: 2014

Journal Articles

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Vladimir I. Vorobyev, MD PhD, Sergei K. Kravchenko, MD PhD, Eduard G. Gemdzhian, PhD, Jana K. Mangasarova, MD PhD, Elena Baryakh, MDPhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD, Kamil Kaplanov, Egor I. Dubrovin, MD, Ivan A Vorobjev, Prof., Natalya G. Turina, MD PhD, Valeri G. Savchenko, MD Prof.

Blood (2014) 124 (21): 1726.

https://doi.org/10.1182/blood.V124.21.1726.1726

Published: 2014

Journal Articles

Hemostatic Disorders and Thrombotic Events in Multiple Myeloma Patients during Peripheral Blood Stem Cell Mobilization

Evdokia S. Urnova, MD PhD, Larisa P. Mendeleeva, MD PhD Prof., Olga S. Pokrovskaya, MD PhD, Marina A. Gracheva, PhD, Eduard G. Gemdzhian, PhD, Ivan D. Tarandovsky, PhD, Maiia V. Firsova, MD, Mariya V. Nareiko, MD, Sergei A. Vasil'ev, MD PhD Prof., Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 1131.

https://doi.org/10.1182/blood.V124.21.1131.1131

Published: 2014

NARROW

The Possibilities of Diffusion-Weighted Magnetic Resonance Imaging in Determining the Burden of a Tumor in Patients with Follicular Lymphoma

Efficacy of Maintenance Therapy Following Auto-HSCT Depending on MRD Status in Patients with Multiple Myeloma

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)

Intensive Chemotherapy of 107 Primary Mediastinal B-Cell Lymphoma Patients. Single Center Experience

Hemostasis in Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy

Clinical and Morphological Features of Different Variants Castleman's Disease

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Front-Line High Dose Therapy with Following Autologous Stem Cell Transplantation (ASCT) for Follicular Lymphoma Patients

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Hemostatic Disorders and Thrombotic Events in Multiple Myeloma Patients during Peripheral Blood Stem Cell Mobilization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only